Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Review
[키워드] Activation
acute respiratory distress
acute respiratory syndrome
alveolar cell
Anti-inflammatory
anti-inflammatory drug
antiviral drug
B cell
candidate
cascade
caused
cells
characterized
Chronic diseases
Complication
complications
coronavirus
Coronavirus disease 2019
counter
COVID-19
COVID-19-related complications
cytokine
Cytokine storm
drug
drugs
dysregulated
effective
elevated
event
function
Genomics
hypercytokinemia
Hyperinflammatory
IL-1
IL-6
Immune cell
Immunity
immunological pathways
immunomodulatory drug
immunomodulatory drugs
immunopathology
Implications
incidence
Inflammatory
Inflammatory cytokines
Inflammatory marker
inflammatory monocyte
Jak
JAK/STAT signaling
lung alveolar
Macrophage
macrophages
measure
mechanisms
molecular
mortality rate
multiple organ failure
pandemic
pathway
Pathways
Pneumonia
pro-inflammatory cytokine
progression
recruit
reported
review
role
SARS-CoV-2
secretion
severely ill patient
severity
storm
suppressed
survival rate
syndrome
the cytokine storm
the disease
therapeutic drug
Therapies
TNF-α
Trial
viral infection
with COVID-19
[DOI] 10.3390/vaccines9050436 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/vaccines9050436 PMC 바로가기 [Article Type] Review